Alexza Pharmaceuticals Inc (NASDAQ:ALXA)
An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
An FDA catalyst play and technically oversold.
Recs
Everything I read says this stock was going to double when I bought it at 1.45 a month or so ago. I still feel very good about and I think it is still undervalued.
Recs
Ascending Triangle
Recs
Great pipeline, well funded.
Recs
Upcoming catalysts that will provide a high run up before pdufa. Between the upcoming rally, the potential of az-004, and their drug delivery technology this can be a multi-bagger by the end of the year and in the long term/
Recs
Alexza is a strong company with a great pipeline!
Recs
ALXA is a stock that returns the favor in the risk you put in to it. I wouldnt be surprised if it hits 4.50 a share.
Recs
ALXA will be back to $2 in several months. I will tell you the reason later LOL
Recs
Stock gets a second chance to make their points in person to FDA. Low price right now. Much needed drug, takes agitation off of schizophrenia and Bipolor patients.
Recs
The company can address the safety issues from the recent CRL, and investors will greet the upcoming announcement of an FDA meeting date with optimism. Concerns of dilution down the road will be put aside in a run up off recent lows.
Recs
Good drug.. will get approval!!!
Recs
Betting on approval
Recs
I am looking for at least a doulbe from here into october.
Recs
Recs
Time to double down on Alexza
Recs
numerous smart fools...
Recs
This is a sinking ship. This stock has been shot by freakin' sharks that have freakin' laser beams attached to their freakin' heads.
Recs
need my meds
Recs
THIS STOCK IS READY, NEW BOARD MEMBER KEY.
Recs
This is for purely speculative cash for now. Per share, it's losing money, suggesting it's living on venture capitol while its novel medicine delivery device (medication absorbed as a mist/vapor via inhalation) completes its trials. It recently signed a deal with ALV presumably to manufacture that part of the device actually responsible for vaporizing the medication.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 32 : 1 2 Next »